Home -> Law Blog Directory -> Personal Injury Law Blogs -> Drug and Device Law
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: Drug and Device LawSo Little Time, So Much To Blog! (Negrete v. Allianz)
By James M. Beck and Mark Herrmann
When federal courts preliminarily approve class action settlements, however, they often enjoin prosecution of competing cases that could interfere with the settlement. Federal courts issue those injunctions under the "in aid of jurisdiction" exception to the Anti-Injunction Act. See 28 U.S.C. Sec. 2283.
Last week, the Ninth Circuit issued an opinion analyzing this obscure, but critically important, aspect of federal procedure. The Ninth Circuit held that where a classwide settlement was not imminent, a trial court did not have authority to effectively enjoin other courts from overseeing settlement talks.
A description of Negrete v. Allianz Life Insurance Co. of North America, 2008 WL 1868993, along with the key money quotes, appears here at the Mass Tort Litigation Blog.
Full post as published by Drug and Device Law on May 06, 2008 (boomark / email).
Elderly Annuities
Allianz Life Insurance Co. agrees to $10 million insurance malpractice settlement.
Cipro
The FDA is seeking to add black box warnings of the risk of tendon rupture associated with Cipro and Levaquin.
The ruptures can involve Achilles tendon, shoulder, hand, bicep or thumb tendons, and is especially increased in patients older than 60, or people who have received kidney, heart or lung transplants, as well as people on steroid therapy...

New Ninth Circuit class action decision: Negrete v. Allianz Life Insurance Co.
Ninth Circuit Opinion on Anti-Injunction Act
Provisionskürzungen für Versicherungsvertreter der Allianz unwirksam
Allianz verliert Prozess gegen Vertreter








